Mauremys reevesii isolate NIE-2019 linkage group 27, ASM1616193v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Geoemydidae; Geoemydinae; Mauremys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028002.1.\nAssembly name: ASM1616193v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Anhui normal university on\n2020/12/22. The original whole-genome shotgun project has the\naccession JADWOL000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Anhui normal university\nAssembly Date :: MAY-2019\nAssembly Method :: NextDenovo v. 2.0-beta.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 96.7x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Mauremys reevesii Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.5\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC120392226, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC120392226, transcript variant X4
uncharacterized LOC120392226, transcript variant X2
uncharacterized LOC120392226, transcript variant X3
uncharacterized protein LOC120392226 isoform X1
uncharacterized protein LOC120392226 isoform X4
uncharacterized protein LOC120392226 isoform X2
uncharacterized protein LOC120392226 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
integrin subunit beta 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
integrin subunit beta 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EF-hand calcium-binding domain-containing protein 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EF-hand calcium binding domain 3, transcript variant X4
EF-hand calcium binding domain 3, transcript variant X1
EF-hand calcium binding domain 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EF-hand calcium binding domain 3, transcript variant X3
EF-hand calcium-binding domain-containing protein 3 isoform X1
EF-hand calcium-binding domain-containing protein 3 isoform X4
EF-hand calcium-binding domain-containing protein 3 isoform X2
EF-hand calcium-binding domain-containing protein 3 isoform X3
uncharacterized LOC120392313, transcript variant X3
uncharacterized LOC120392313, transcript variant X4
uncharacterized LOC120392313, transcript variant X2
uncharacterized LOC120392313, transcript variant X1
uncharacterized LOC120392313, transcript variant X5
methyltransferase like 2A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methyltransferase like 2A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
methyltransferase like 2A, transcript variant X7
methyltransferase like 2A, transcript variant X6
methyltransferase like 2A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
methyltransferase like 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
methyltransferase like 2A, transcript variant X2
tRNA N(3)-methylcytidine methyltransferase METTL2A isoform X3
tRNA N(3)-methylcytidine methyltransferase METTL2A isoform X5
tRNA N(3)-methylcytidine methyltransferase METTL2A isoform X4
tRNA N(3)-methylcytidine methyltransferase METTL2A isoform X1
tRNA N(3)-methylcytidine methyltransferase METTL2A isoform X2
tousled like kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tousled like kinase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tousled like kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tousled like kinase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tousled like kinase 2, transcript variant X1
serine/threonine-protein kinase tousled-like 2 isoform X1
serine/threonine-protein kinase tousled-like 2 isoform X3
serine/threonine-protein kinase tousled-like 2 isoform X2
serine/threonine-protein kinase tousled-like 2 isoform X4
mannose receptor C type 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mannose receptor C type 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane associated ring-CH-type finger 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
membrane associated ring-CH-type finger 10, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
membrane associated ring-CH-type finger 10, transcript variant X1
membrane associated ring-CH-type finger 10, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane associated ring-CH-type finger 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable E3 ubiquitin-protein ligase MARCHF10 isoform X3
probable E3 ubiquitin-protein ligase MARCHF10 isoform X1
membrane associated ring-CH-type finger 10, transcript variant X5
probable E3 ubiquitin-protein ligase MARCHF10 isoform X2
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X5
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X8
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X7
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X6
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X16
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X17
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X11
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X12
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X20
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X4
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X2
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X3
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X10
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X21
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X15
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X14
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X1
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X19
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X18
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X22
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
angiotensin I converting enzyme, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
angiotensin I converting enzyme, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
angiotensin I converting enzyme, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
angiotensin-converting enzyme isoform X1
angiotensin I converting enzyme, transcript variant X4
angiotensin-converting enzyme isoform X2
angiotensin I converting enzyme, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
angiotensin-converting enzyme isoform X3
potassium voltage-gated channel subfamily H member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily H member 6 isoform X1
potassium voltage-gated channel subfamily H member 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily H member 6 isoform X4
potassium voltage-gated channel subfamily H member 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily H member 6, transcript variant X3
potassium voltage-gated channel subfamily H member 6 isoform X3
potassium voltage-gated channel subfamily H member 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitogen-activated protein kinase kinase kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 3 isoform X1
mitogen-activated protein kinase kinase kinase 3 isoform X2
mitogen-activated protein kinase kinase kinase 3, transcript variant X3
mitogen-activated protein kinase kinase kinase 3 isoform X3
LIM domain containing 2, transcript variant X2
LIM domain containing 2, transcript variant X3
LIM domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LIM domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LIM domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LIM domain-containing protein 2 isoform X2
LIM domain-containing protein 2 isoform X3
LIM domain-containing protein 2 isoform X1
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF113A-like isoform X1
E3 ubiquitin-protein ligase RNF113A-like, transcript variant X2
E3 ubiquitin-protein ligase RNF113A-like isoform X2
STE20 related adaptor alpha, transcript variant X11
STE20 related adaptor alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
STE20 related adaptor alpha, transcript variant X9
STE20 related adaptor alpha, transcript variant X7
STE20 related adaptor alpha, transcript variant X13
STE20 related adaptor alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
STE20 related adaptor alpha, transcript variant X10
STE20 related adaptor alpha, transcript variant X8
STE20 related adaptor alpha, transcript variant X6
STE20 related adaptor alpha, transcript variant X2
STE20 related adaptor alpha, transcript variant X4
STE20 related adaptor alpha, transcript variant X12
STE20 related adaptor alpha, transcript variant X5
STE20-related kinase adapter protein alpha isoform X2
STE20-related kinase adapter protein alpha isoform X1
STE20-related kinase adapter protein alpha isoform X3
STE20-related kinase adapter protein alpha isoform X4
coiled-coil domain containing 47, transcript variant X3
coiled-coil domain containing 47, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain containing 47, transcript variant X4
coiled-coil domain containing 47, transcript variant X1
coiled-coil domain-containing protein 47 isoform X1
coiled-coil domain-containing protein 47 isoform X2
coiled-coil domain-containing protein 47 isoform X3
DEAD-box helicase 42, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DEAD-box helicase 42, transcript variant X5
DEAD-box helicase 42, transcript variant X2
DEAD-box helicase 42, transcript variant X4
DEAD-box helicase 42, transcript variant X3
ATP-dependent RNA helicase DDX42 isoform X1
ATP-dependent RNA helicase DDX42 isoform X2
parathyroid hormone/parathyroid hormone-related peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle 27, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle 27, transcript variant X6
cell division cycle 27, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell division cycle 27, transcript variant X2
cell division cycle 27, transcript variant X4
cell division cycle 27, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cell division cycle protein 27 homolog isoform X1
cell division cycle protein 27 homolog isoform X2
cell division cycle protein 27 homolog isoform X3
cell division cycle protein 27 homolog isoform X4
cell division cycle protein 27 homolog isoform X5
cell division cycle protein 27 homolog isoform X6
KAT8 regulatory NSL complex subunit 1, transcript variant X2
KAT8 regulatory NSL complex subunit 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 1, transcript variant X5
KAT8 regulatory NSL complex subunit 1, transcript variant X1
KAT8 regulatory NSL complex subunit 1, transcript variant X6
KAT8 regulatory NSL complex subunit 1, transcript variant X3
KAT8 regulatory NSL complex subunit 1 isoform X1
KAT8 regulatory NSL complex subunit 1 isoform X2
KAT8 regulatory NSL complex subunit 1 isoform X3
microtubule associated protein tau, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microtubule associated protein tau, transcript variant X16
microtubule associated protein tau, transcript variant X13
microtubule associated protein tau, transcript variant X21
microtubule associated protein tau, transcript variant X17
microtubule associated protein tau, transcript variant X12
microtubule associated protein tau, transcript variant X22
microtubule associated protein tau, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microtubule associated protein tau, transcript variant X14
microtubule associated protein tau, transcript variant X18
microtubule associated protein tau, transcript variant X5
microtubule associated protein tau, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microtubule associated protein tau, transcript variant X7
microtubule associated protein tau, transcript variant X8
microtubule associated protein tau, transcript variant X11
microtubule associated protein tau, transcript variant X10
microtubule associated protein tau, transcript variant X9
microtubule associated protein tau, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
microtubule associated protein tau, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
microtubule associated protein tau, transcript variant X3
microtubule associated protein tau, transcript variant X1
microtubule-associated protein tau isoform X15
microtubule-associated protein tau isoform X12
microtubule-associated protein tau isoform X9
microtubule-associated protein tau isoform X17
microtubule-associated protein tau isoform X13
microtubule-associated protein tau isoform X8
microtubule-associated protein tau isoform X18
microtubule-associated protein tau isoform X16
microtubule-associated protein tau isoform X10
microtubule-associated protein tau isoform X14
microtubule-associated protein tau isoform X5
microtubule-associated protein tau isoform X6
microtubule-associated protein tau isoform X11
microtubule-associated protein tau isoform X7
microtubule-associated protein tau isoform X4
microtubule-associated protein tau isoform X3
microtubule-associated protein tau isoform X1
microtubule associated protein tau, transcript variant X2
microtubule-associated protein tau isoform X2
solute carrier family 25 member 39, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 25 member 39, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 25 member 39, transcript variant X2
solute carrier family 25 member 39 isoform X1
solute carrier family 25 member 39 isoform X4
solute carrier family 25 member 39 isoform X2
solute carrier family 25 member 39, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 25 member 39 isoform X3
solute carrier family 25 member 39, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 25 member 39 isoform X5
RUN domain containing 3A, transcript variant X3
RUN domain containing 3A, transcript variant X2
RUN domain containing 3A, transcript variant X1
RUN domain-containing protein 3A isoform X2
RUN domain-containing protein 3A isoform X1
RUN domain-containing protein 3A isoform X3
RUN domain containing 3A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 4 member 1 (Diego blood group), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 4 member 1 (Diego blood group), transcript variant X1
upstream binding transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
upstream binding transcription factor, transcript variant X8
upstream binding transcription factor, transcript variant X1
upstream binding transcription factor, transcript variant X3
upstream binding transcription factor, transcript variant X9
upstream binding transcription factor, transcript variant X4
upstream binding transcription factor, transcript variant X6
upstream binding transcription factor, transcript variant X7
upstream binding transcription factor, transcript variant X5
nucleolar transcription factor 1 isoform X1
nucleolar transcription factor 1 isoform X3
nucleolar transcription factor 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane and ubiquitin like domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane and ubiquitin like domain containing 2, transcript variant X3
transmembrane and ubiquitin like domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane and ubiquitin-like domain-containing protein 2
ankyrin repeat and SOCS box containing 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
homologous recombination factor with OB-fold
homologous recombination OB-fold protein
histone deacetylase 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone deacetylase 5, transcript variant X4
histone deacetylase 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone deacetylase 5, transcript variant X5
histone deacetylase 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone deacetylase 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glucose-6-phosphatase catalytic subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 101, transcript variant X2
transmembrane protein 101, transcript variant X1
transmembrane protein 101, transcript variant X5
transmembrane protein 101, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 101, transcript variant X3
transmembrane protein 101, transcript variant X6
transmembrane protein 101, transcript variant X7
N-acetylglutamate synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-acetylglutamate synthase, transcript variant X1
N-acetylglutamate synthase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
membrane palmitoylated protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane palmitoylated protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
membrane palmitoylated protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane palmitoylated protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
membrane palmitoylated protein 2, transcript variant X4
membrane palmitoylated protein 2, transcript variant X1
membrane palmitoylated protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
sarcoglycan alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sarcoglycan alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sarcoglycan alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 9B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pyruvate dehydrogenase kinase, isozyme 2
integrin subunit alpha 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
integrin subunit alpha 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lysine acetyltransferase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lysine acetyltransferase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
histone acetyltransferase KAT7 isoform X2
histone acetyltransferase KAT7 isoform X1
uncharacterized LOC120392031, transcript variant X1
uncharacterized LOC120392031, transcript variant X2
uncharacterized LOC120392031, transcript variant X6
uncharacterized LOC120392031, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC120392031, transcript variant X7
uncharacterized LOC120392031, transcript variant X3
uncharacterized LOC120392031, transcript variant X9
uncharacterized LOC120392031, transcript variant X8
uncharacterized LOC120392031, transcript variant X10
uncharacterized LOC120392031, transcript variant X5
family with sequence similarity 117 member A, transcript variant X1
family with sequence similarity 117 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
family with sequence similarity 117 member A, transcript variant X3
uncharacterized LOC120392036, transcript variant X1
uncharacterized LOC120392036, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC120392032, transcript variant X3
uncharacterized LOC120392032, transcript variant X4
uncharacterized LOC120392032, transcript variant X5
uncharacterized LOC120392032, transcript variant X2
uncharacterized LOC120392032, transcript variant X1
speckle type BTB/POZ protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
speckle type BTB/POZ protein, transcript variant X1
speckle type BTB/POZ protein, transcript variant X5
speckle type BTB/POZ protein, transcript variant X6
speckle type BTB/POZ protein, transcript variant X9
speckle type BTB/POZ protein, transcript variant X3
speckle type BTB/POZ protein, transcript variant X11
speckle type BTB/POZ protein, transcript variant X12
speckle type BTB/POZ protein, transcript variant X7
speckle type BTB/POZ protein, transcript variant X2
speckle type BTB/POZ protein, transcript variant X8
speckle type BTB/POZ protein, transcript variant X10
uncharacterized LOC120392034, transcript variant X3
uncharacterized LOC120392034, transcript variant X1
uncharacterized LOC120392034, transcript variant X4
uncharacterized LOC120392034, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC120392237, transcript variant X1
uncharacterized LOC120392237, transcript variant X2
tumor necrosis factor receptor superfamily member 16
uncharacterized LOC120392269, transcript variant X2
uncharacterized LOC120392269, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC120392170, transcript variant X2
uncharacterized LOC120392170, transcript variant X1
zinc finger protein 652, transcript variant X3
zinc finger protein 652, transcript variant X1
zinc finger protein 652, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 652, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X1
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X4
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X3
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X6
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X8
phosphoethanolamine/phosphocholine phosphatase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphoethanolamine/phosphocholine phosphatase
ABI family member 3, transcript variant X4
ABI family member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ABI family member 3, transcript variant X2
ABI family member 3, transcript variant X5
ABI family member 3, transcript variant X3
ABI family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein subunit gamma transducin 2, transcript variant X2
G protein subunit gamma transducin 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X2
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X3
beta-1,4 N-acetylgalactosaminyltransferase 2-like, transcript variant X4
beta-1,4 N-acetylgalactosaminyltransferase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
insulin like growth factor 2 mRNA binding protein 1, transcript variant X2
insulin like growth factor 2 mRNA binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
insulin-like growth factor 2 mRNA-binding protein 1 isoform X2
insulin-like growth factor 2 mRNA-binding protein 1 isoform X1
pro-glucagon-like, transcript variant X8
pro-glucagon-like, transcript variant X9
pro-glucagon-like, transcript variant X10
pro-glucagon-like, transcript variant X2
pro-glucagon-like, transcript variant X3
pro-glucagon-like, transcript variant X1
pro-glucagon-like, transcript variant X11
pro-glucagon-like, transcript variant X4
pro-glucagon-like, transcript variant X5
pro-glucagon-like, transcript variant X6
pro-glucagon-like, transcript variant X7
SNF8 subunit of ESCRT-II, transcript variant X2
SNF8 subunit of ESCRT-II, transcript variant X1
ubiquitin conjugating enzyme E2 Z, transcript variant X3
ubiquitin conjugating enzyme E2 Z, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 Z, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 Z isoform X3
ubiquitin-conjugating enzyme E2 Z isoform X2
ubiquitin-conjugating enzyme E2 Z isoform X1
ATP synthase membrane subunit c locus 1, transcript variant X1
ATP synthase membrane subunit c locus 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATP synthase F(0) complex subunit C1, mitochondrial isoform X1
ATP synthase F(0) complex subunit C1, mitochondrial isoform X2
calcium binding and coiled-coil domain 2, transcript variant X1
calcium binding and coiled-coil domain 2, transcript variant X2
calcium binding and coiled-coil domain 2, transcript variant X3
calcium-binding and coiled-coil domain-containing protein 2 isoform X1
calcium-binding and coiled-coil domain-containing protein 2 isoform X2
calcium-binding and coiled-coil domain-containing protein 2 isoform X3
tubulin tyrosine ligase like 6, transcript variant X1
tubulin polyglutamylase TTLL6 isoform X1
tubulin tyrosine ligase like 6, transcript variant X4
tubulin tyrosine ligase like 6, transcript variant X2
tubulin tyrosine ligase like 6, transcript variant X3
tubulin tyrosine ligase like 6, transcript variant X5
tubulin polyglutamylase TTLL6 isoform X2
tubulin polyglutamylase TTLL6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC120392306, transcript variant X2
uncharacterized LOC120392306, transcript variant X1
uncharacterized protein LOC120392306 isoform X2
uncharacterized protein LOC120392306 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
src kinase associated phosphoprotein 1, transcript variant X2
src kinase associated phosphoprotein 1, transcript variant X1
src kinase associated phosphoprotein 1, transcript variant X3
src kinase-associated phosphoprotein 1 isoform X3
src kinase-associated phosphoprotein 1 isoform X1
src kinase-associated phosphoprotein 1 isoform X2
nuclear factor, erythroid 2 like 1, transcript variant X2
nuclear factor, erythroid 2 like 1, transcript variant X1
nuclear factor, erythroid 2 like 1, transcript variant X3
endoplasmic reticulum membrane sensor NFE2L1 isoform X1
endoplasmic reticulum membrane sensor NFE2L1 isoform X2
COPI coat complex subunit zeta 2, transcript variant X1
COPI coat complex subunit zeta 2, transcript variant X3
COPI coat complex subunit zeta 2, transcript variant X2
CDK5 regulatory subunit associated protein 3
CDK5 regulatory subunit-associated protein 3
proline rich 15 like, transcript variant X1
proline rich 15 like, transcript variant X2
pyridoxamine 5'-phosphate oxidase, transcript variant X2
pyridoxamine 5'-phosphate oxidase, transcript variant X1
uncharacterized LOC120392108, transcript variant X2
uncharacterized LOC120392108, transcript variant X1
uncharacterized LOC120392108, transcript variant X4
uncharacterized LOC120392108, transcript variant X3
uncharacterized LOC120392108, transcript variant X5
uncharacterized protein LOC120392108 isoform X1
uncharacterized protein LOC120392108 isoform X3
uncharacterized protein LOC120392108 isoform X2
uncharacterized protein LOC120392108 isoform X4
Sp2 transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Sp2 transcription factor, transcript variant X5
Sp2 transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Sp2 transcription factor, transcript variant X2
Sp2 transcription factor, transcript variant X4
Sp6 transcription factor, transcript variant X2
Sp6 transcription factor, transcript variant X1
Sp6 transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing protein 46
mitochondrial ribosomal protein L10, transcript variant X1
mitochondrial ribosomal protein L10, transcript variant X2
39S ribosomal protein L10, mitochondrial isoform X1
mitochondrial ribosomal protein L10, transcript variant X3
39S ribosomal protein L10, mitochondrial isoform X2
oxysterol binding protein like 7, transcript variant X2
oxysterol binding protein like 7, transcript variant X4
oxysterol binding protein like 7, transcript variant X5
oxysterol binding protein like 7, transcript variant X3
oxysterol binding protein like 7, transcript variant X1
oxysterol binding protein like 7, transcript variant X6
oxysterol binding protein like 7, transcript variant X7
oxysterol-binding protein-related protein 7 isoform X1
oxysterol-binding protein-related protein 7 isoform X2
oxysterol-binding protein-related protein 7 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TBK1 binding protein 1, transcript variant X3
TBK1 binding protein 1, transcript variant X2
TBK1 binding protein 1, transcript variant X1
TANK-binding kinase 1-binding protein 1 isoform X2
TANK-binding kinase 1-binding protein 1 isoform X1
aminopeptidase puromycin sensitive, transcript variant X1
aminopeptidase puromycin sensitive, transcript variant X3
aminopeptidase puromycin sensitive, transcript variant X2
puromycin-sensitive aminopeptidase isoform X1
puromycin-sensitive aminopeptidase isoform X3
puromycin-sensitive aminopeptidase isoform X2
39S ribosomal protein L45, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: suppressor of cytokine signaling 7
Rho GTPase activating protein 23, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 23 isoform X5
Rho GTPase activating protein 23, transcript variant X4
rho GTPase-activating protein 23 isoform X4
Rho GTPase activating protein 23, transcript variant X2
Rho GTPase activating protein 23, transcript variant X1
Rho GTPase activating protein 23, transcript variant X3
Rho GTPase activating protein 23, transcript variant X6
Rho GTPase activating protein 23, transcript variant X7
rho GTPase-activating protein 23 isoform X1
rho GTPase-activating protein 23 isoform X2
rho GTPase-activating protein 23 isoform X3
rho GTPase-activating protein 23 isoform X6
SRC kinase signaling inhibitor 1, transcript variant X2
SRC kinase signaling inhibitor 1, transcript variant X14
SRC kinase signaling inhibitor 1, transcript variant X13
SRC kinase signaling inhibitor 1, transcript variant X1
SRC kinase signaling inhibitor 1, transcript variant X4
SRC kinase signaling inhibitor 1, transcript variant X3
SRC kinase signaling inhibitor 1, transcript variant X12
SRC kinase signaling inhibitor 1, transcript variant X5
SRC kinase signaling inhibitor 1, transcript variant X9
SRC kinase signaling inhibitor 1, transcript variant X10
SRC kinase signaling inhibitor 1, transcript variant X11
SRC kinase signaling inhibitor 1 isoform X2
SRC kinase signaling inhibitor 1 isoform X10
SRC kinase signaling inhibitor 1 isoform X9
SRC kinase signaling inhibitor 1 isoform X1
SRC kinase signaling inhibitor 1 isoform X3
SRC kinase signaling inhibitor 1 isoform X8
SRC kinase signaling inhibitor 1 isoform X7
SRC kinase signaling inhibitor 1, transcript variant X15
SRC kinase signaling inhibitor 1, transcript variant X6
SRC kinase signaling inhibitor 1, transcript variant X7
SRC kinase signaling inhibitor 1 isoform X11
SRC kinase signaling inhibitor 1 isoform X4
SRC kinase signaling inhibitor 1 isoform X5
SRC kinase signaling inhibitor 1, transcript variant X8
SRC kinase signaling inhibitor 1 isoform X6
elongin BC and polycomb repressive complex 2 associated protein
elongin BC and Polycomb repressive complex 2-associated protein
MLLT6, PHD finger containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
MLLT6, PHD finger containing, transcript variant X3
MLLT6, PHD finger containing, transcript variant X2
MLLT6, PHD finger containing, transcript variant X4
MLLT6, PHD finger containing, transcript variant X5
CDGSH iron sulfur domain 3, transcript variant X2
CDGSH iron sulfur domain 3, transcript variant X1
CDGSH iron-sulfur domain-containing protein 3, mitochondrial isoform X1
CDGSH iron-sulfur domain-containing protein 3, mitochondrial isoform X2
polycomb group ring finger 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polycomb group ring finger 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
polycomb group ring finger 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
polycomb group ring finger 2, transcript variant X4
polycomb group ring finger 2, transcript variant X2
polycomb group ring finger 2, transcript variant X5
polycomb group RING finger protein 2 isoform X2
polycomb group RING finger protein 2 isoform X1
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatidylinositol-5-phosphate 4-kinase type 2 beta
phosphatidylinositol 5-phosphate 4-kinase type-2 beta
CWC25 spliceosome associated protein homolog, transcript variant X1
CWC25 spliceosome associated protein homolog, transcript variant X2
pre-mRNA-splicing factor CWC25 homolog isoform X1
pre-mRNA-splicing factor CWC25 homolog isoform X2
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized protein C17orf98 homolog
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00412
uncharacterized LOC120392268, transcript variant X2
uncharacterized LOC120392268, transcript variant X1
LIM and SH3 protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LIM and SH3 protein 1, transcript variant X2
plexin domain containing 1, transcript variant X4
plexin domain containing 1, transcript variant X1
plexin domain containing 1, transcript variant X5
plexin domain containing 1, transcript variant X2
plexin domain containing 1, transcript variant X3
ADP ribosylation factor like GTPase 5C, transcript variant X3
ADP ribosylation factor like GTPase 5C, transcript variant X1
ADP ribosylation factor like GTPase 5C, transcript variant X2
putative ADP-ribosylation factor-like protein 5C isoform X3
putative ADP-ribosylation factor-like protein 5C isoform X1
putative ADP-ribosylation factor-like protein 5C isoform X2
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X3
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X2
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X1
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X4
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X8
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X7
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X5
voltage-dependent L-type calcium channel subunit beta-1 isoform X6
voltage-dependent L-type calcium channel subunit beta-1 isoform X3
voltage-dependent L-type calcium channel subunit beta-1 isoform X2
voltage-dependent L-type calcium channel subunit beta-1 isoform X1
voltage-dependent L-type calcium channel subunit beta-1 isoform X4
voltage-dependent L-type calcium channel subunit beta-1 isoform X8
voltage-dependent L-type calcium channel subunit beta-1 isoform X7
voltage-dependent L-type calcium channel subunit beta-1 isoform X5
calcium voltage-gated channel auxiliary subunit beta 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit beta-1 isoform X9
P43 5S RNA-binding protein-like, transcript variant X3
P43 5S RNA-binding protein-like isoform X3
P43 5S RNA-binding protein-like, transcript variant X1
P43 5S RNA-binding protein-like, transcript variant X2
P43 5S RNA-binding protein-like isoform X1
P43 5S RNA-binding protein-like isoform X2
SH3 and cysteine-rich domain-containing protein 2
F-box and leucine rich repeat protein 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
F-box and leucine rich repeat protein 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
F-box and leucine rich repeat protein 20, transcript variant X6
F-box and leucine rich repeat protein 20, transcript variant X4
F-box and leucine rich repeat protein 20, transcript variant X5
F-box and leucine rich repeat protein 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
F-box and leucine rich repeat protein 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
F-box and leucine rich repeat protein 20, transcript variant X8
mediator complex subunit 1, transcript variant X1
mediator complex subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mediator of RNA polymerase II transcription subunit 1 isoform X2
mediator of RNA polymerase II transcription subunit 1 isoform X1
cyclin dependent kinase 12, transcript variant X2
cyclin dependent kinase 12, transcript variant X1
cyclin dependent kinase 12, transcript variant X5
cyclin dependent kinase 12, transcript variant X3
cyclin dependent kinase 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 1B
protein phosphatase 1 regulatory subunit 1B
StAR related lipid transfer domain containing 3, transcript variant X1
StAR related lipid transfer domain containing 3, transcript variant X5
StAR related lipid transfer domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
StAR related lipid transfer domain containing 3, transcript variant X4
StAR related lipid transfer domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
stAR-related lipid transfer protein 3 isoform X1
stAR-related lipid transfer protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
post-GPI attachment to proteins phospholipase 3, transcript variant X2
post-GPI attachment to proteins phospholipase 3, transcript variant X1
post-GPI attachment to proteins factor 3 isoform X1
post-GPI attachment to proteins phospholipase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
post-GPI attachment to proteins factor 3 isoform X3
post-GPI attachment to proteins factor 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
growth factor receptor bound protein 7, transcript variant X2
growth factor receptor bound protein 7, transcript variant X1
growth factor receptor-bound protein 7 isoform X1
growth factor receptor-bound protein 7 isoform X2
growth factor receptor bound protein 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
growth factor receptor bound protein 7, transcript variant X5
growth factor receptor bound protein 7, transcript variant X6
growth factor receptor bound protein 7, transcript variant X4
growth factor receptor-bound protein 7 isoform X3
retinol dehydrogenase 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
retinol dehydrogenase 8-like, transcript variant X1
IKAROS family zinc finger 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
IKAROS family zinc finger 3, transcript variant X5
IKAROS family zinc finger 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
IKAROS family zinc finger 3, transcript variant X3
IKAROS family zinc finger 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zona pellucida binding protein 2, transcript variant X3
zona pellucida binding protein 2, transcript variant X1
zona pellucida binding protein 2, transcript variant X2
zona pellucida-binding protein 2 isoform X1
zona pellucida-binding protein 2 isoform X2
zona pellucida-binding protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat-containing protein 3C
ORMDL sphingolipid biosynthesis regulator 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ORMDL sphingolipid biosynthesis regulator 3, transcript variant X4
ORMDL sphingolipid biosynthesis regulator 3, transcript variant X5
ORMDL sphingolipid biosynthesis regulator 3, transcript variant X3
ORMDL sphingolipid biosynthesis regulator 3, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: 26S proteasome non-ATPase regulatory subunit 3
colony stimulating factor 3, transcript variant X1
granulocyte colony-stimulating factor isoform X1
colony stimulating factor 3, transcript variant X2
granulocyte colony-stimulating factor isoform X2
mediator complex subunit 24, transcript variant X3
mediator complex subunit 24, transcript variant X2
mediator complex subunit 24, transcript variant X1
mediator of RNA polymerase II transcription subunit 24 isoform X2
mediator of RNA polymerase II transcription subunit 24 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01211
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear receptor subfamily 1 group D member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
MSL complex subunit 1, transcript variant X2
MSL complex subunit 1, transcript variant X1
male-specific lethal 1 homolog isoform X1
male-specific lethal 1 homolog isoform X2
MSL complex subunit 1, transcript variant X3
MSL complex subunit 1, transcript variant X4
male-specific lethal 1 homolog isoform X3
male-specific lethal 1 homolog isoform X4
CASC3 exon junction complex subunit, transcript variant X2
CASC3 exon junction complex subunit, transcript variant X1
Rap guanine nucleotide exchange factor like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rap guanine nucleotide exchange factor-like 1 isoform X1
Rap guanine nucleotide exchange factor like 1, transcript variant X2
rap guanine nucleotide exchange factor-like 1 isoform X2
WAS/WASL interacting protein family member 2, transcript variant X2
WAS/WASL interacting protein family member 2, transcript variant X3
WAS/WASL interacting protein family member 2, transcript variant X1
WAS/WASL interacting protein family member 2, transcript variant X8
WAS/WASL interacting protein family member 2, transcript variant X9
WAS/WASL interacting protein family member 2, transcript variant X6
WAS/WASL interacting protein family member 2, transcript variant X7
WAS/WASL interacting protein family member 2, transcript variant X5
WAS/WASL interacting protein family member 2, transcript variant X4
WAS/WASL-interacting protein family member 2 isoform X1
WAS/WASL-interacting protein family member 2 isoform X2
WAS/WASL-interacting protein family member 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
retinoic acid receptor alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
retinoic acid receptor alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gap junction protein delta 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gap junction protein delta 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA topoisomerase II alpha, transcript variant X2
DNA topoisomerase II alpha, transcript variant X1
collagen alpha-1(X) chain-like, transcript variant X2
collagen alpha-1(X) chain-like, transcript variant X1
collagen alpha-1(X) chain-like isoform X2
collagen alpha-1(X) chain-like isoform X1
insulin like growth factor binding protein 4
insulin-like growth factor-binding protein 4
uncharacterized LOC120392281, transcript variant X4
uncharacterized LOC120392281, transcript variant X6
uncharacterized LOC120392281, transcript variant X1
uncharacterized LOC120392281, transcript variant X5
uncharacterized LOC120392281, transcript variant X2
uncharacterized LOC120392281, transcript variant X3
C-C motif chemokine receptor 7, transcript variant X1
C-C motif chemokine receptor 7, transcript variant X3
C-C motif chemokine receptor 7, transcript variant X2
C-C chemokine receptor type 7 isoform X1
C-C chemokine receptor type 7 isoform X2
C-C chemokine receptor type 7 isoform X3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1, transcript variant X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 isoform X1
uncharacterized LOC120392156, transcript variant X1
uncharacterized LOC120392156, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
keratin, type I cytoskeletal 24-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 183 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
keratin, type I cytoskeletal 24-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 183 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
keratin, type I cytoskeletal 24-like, transcript variant X2
keratin, type I cytoskeletal 24-like isoform X3
keratin, type I cytoskeletal 24-like isoform X1
keratin, type I cytoskeletal 24-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 202 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
keratin, type I cytoskeletal 19-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 206 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
keratin, type I cytoskeletal 19-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 203 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
keratin, type I cytoskeletal 19-like isoform X1
keratin, type I cytoskeletal 19-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 205 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 170 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 246 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 311 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 315 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 294 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 245 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 257 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 140 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
huntingtin associated protein 1, transcript variant X1
huntingtin-associated protein 1 isoform X1
huntingtin associated protein 1, transcript variant X2
huntingtin associated protein 1, transcript variant X3
huntingtin-associated protein 1 isoform X2
junction plakoglobin, transcript variant X1
junction plakoglobin, transcript variant X2
prolyl 3-hydroxylase family member 4 (inactive)
peptidyl-prolyl cis-trans isomerase FKBP10
5'-nucleotidase, cytosolic IIIB, transcript variant X1
5'-nucleotidase, cytosolic IIIB, transcript variant X4
5'-nucleotidase, cytosolic IIIB, transcript variant X3
5'-nucleotidase, cytosolic IIIB, transcript variant X2
5'-nucleotidase, cytosolic IIIB, transcript variant X5
5'-nucleotidase, cytosolic IIIB, transcript variant X6
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X1
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X2
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X3
7-methylguanosine phosphate-specific 5'-nucleotidase isoform X4
kelch like family member 10, transcript variant X2
kelch like family member 10, transcript variant X3
kelch like family member 10, transcript variant X1
ATP citrate lyase, transcript variant X4
ATP citrate lyase, transcript variant X1
ATP citrate lyase, transcript variant X2
ATP citrate lyase, transcript variant X3
ATP citrate lyase, transcript variant X5
outer dynein arm docking complex subunit 4, transcript variant X2
outer dynein arm-docking complex subunit 4 isoform X2
outer dynein arm docking complex subunit 4, transcript variant X1
outer dynein arm docking complex subunit 4, transcript variant X3
outer dynein arm docking complex subunit 4, transcript variant X4
outer dynein arm-docking complex subunit 4 isoform X1
outer dynein arm-docking complex subunit 4 isoform X3
outer dynein arm-docking complex subunit 4 isoform X4
2',3'-cyclic nucleotide 3' phosphodiesterase, transcript variant X2
2',3'-cyclic-nucleotide 3'-phosphodiesterase isoform X2
2',3'-cyclic nucleotide 3' phosphodiesterase, transcript variant X3
2',3'-cyclic nucleotide 3' phosphodiesterase, transcript variant X1
2',3'-cyclic-nucleotide 3'-phosphodiesterase isoform X1
2',3'-cyclic-nucleotide 3'-phosphodiesterase isoform X3
DnaJ heat shock protein family (Hsp40) member C7, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C7, transcript variant X4
DnaJ heat shock protein family (Hsp40) member C7, transcript variant X2
dnaJ homolog subfamily C member 7 isoform X1
dnaJ homolog subfamily C member 7 isoform X3
dnaJ homolog subfamily C member 7 isoform X2
dnaJ homolog subfamily C member 7 isoform X4
NFKB inhibitor interacting Ras like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NFKB inhibitor interacting Ras like 2, transcript variant X5
NFKB inhibitor interacting Ras like 2, transcript variant X6
NFKB inhibitor interacting Ras like 2, transcript variant X1
NFKB inhibitor interacting Ras like 2, transcript variant X4
NFKB inhibitor interacting Ras like 2, transcript variant X2
NF-kappa-B inhibitor-interacting Ras-like protein 2
zinc finger protein 385C-like, transcript variant X5
zinc finger protein 385C-like, transcript variant X6
zinc finger protein 385C-like, transcript variant X4
zinc finger protein 385C-like, transcript variant X3
zinc finger protein 385C-like, transcript variant X7
zinc finger protein 385C-like, transcript variant X9
zinc finger protein 385C-like, transcript variant X8
zinc finger protein 385C-like isoform X4
zinc finger protein 385C-like isoform X3
zinc finger protein 385C-like isoform X5
zinc finger protein 385C-like isoform X6
zinc finger protein 385C-like isoform X7
zinc finger protein 385C-like, transcript variant X2
zinc finger protein 385C-like, transcript variant X1
transmembrane protein C17orf113-like isoform X2
transmembrane protein C17orf113-like isoform X1
DExH-box helicase 58, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DExH-box helicase 58, transcript variant X2
DExH-box helicase 58, transcript variant X3
DExH-box helicase 58, transcript variant X1
DExH-box helicase 58, transcript variant X4
probable ATP-dependent RNA helicase DHX58
lysine acetyltransferase 2A, transcript variant X2
lysine acetyltransferase 2A, transcript variant X1
lysine acetyltransferase 2A, transcript variant X3
histone acetyltransferase KAT2A isoform X2
histone acetyltransferase KAT2A isoform X1
histone acetyltransferase KAT2A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium voltage-gated channel subfamily H member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
inactive phospholipase C-like protein 2, transcript variant X1
inactive phospholipase C-like protein 2, transcript variant X2
inactive phospholipase C-like protein 2 isoform X1
inactive phospholipase C-like protein 2 isoform X2
signal transducer and activator of transcription 5B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X2
signal transducer and activator of transcription 5B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X4
signal transducer and activator of transcription 5B, transcript variant X6
signal transducer and activator of transcription 5B, transcript variant X5
signal transducer and activator of transcription 5B
signal transducer and activator of transcription 5B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
signal transducer and activator of transcription 5B-like, transcript variant X1
signal transducer and activator of transcription 5B-like
signal transducer and activator of transcription 3, transcript variant X2
signal transducer and activator of transcription 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
signal transducer and activator of transcription 3, transcript variant X1
signal transducer and activator of transcription 3 isoform X1
signal transducer and activator of transcription 3 isoform X2
signal transducer and activator of transcription 3, transcript variant X4
signal transducer and activator of transcription 3 isoform X3
caveolae associated protein 1, transcript variant X2
caveolae associated protein 1, transcript variant X6
caveolae associated protein 1, transcript variant X7
caveolae associated protein 1, transcript variant X5
caveolae associated protein 1, transcript variant X4
caveolae associated protein 1, transcript variant X3
caveolae associated protein 1, transcript variant X1
ATPase H+ transporting V0 subunit a1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ATPase H+ transporting V0 subunit a1, transcript variant X1
ATPase H+ transporting V0 subunit a1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATPase H+ transporting V0 subunit a1, transcript variant X3
V-type proton ATPase 116 kDa subunit a1 isoform X4
V-type proton ATPase 116 kDa subunit a1 isoform X1
V-type proton ATPase 116 kDa subunit a1 isoform X2
V-type proton ATPase 116 kDa subunit a1 isoform X3
serine/threonine-protein kinase 17A-like
N-acetyl-alpha-glucosaminidase, transcript variant X2
N-acetyl-alpha-glucosaminidase, transcript variant X3
N-acetyl-alpha-glucosaminidase, transcript variant X1
alpha-N-acetylglucosaminidase isoform X2
alpha-N-acetylglucosaminidase isoform X3
alpha-N-acetylglucosaminidase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coenzyme Q-binding protein COQ10 homolog B, mitochondrial-like
reticulophagy regulator family member 3, transcript variant X3
reticulophagy regulator family member 3, transcript variant X1
reticulophagy regulator family member 3, transcript variant X5
reticulophagy regulator family member 3, transcript variant X4
reticulophagy regulator family member 3, transcript variant X2
pleckstrin homology, MyTH4 and FERM domain containing H3, transcript variant X2
pleckstrin homology, MyTH4 and FERM domain containing H3, transcript variant X1
pleckstrin homology domain-containing family H member 3 isoform X2
pleckstrin homology domain-containing family H member 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
contactin associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
contactin associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
contactin-associated protein 1 isoform X1
contactin-associated protein 1 isoform X2
enhancer of zeste 1 polycomb repressive complex 2 subunit, transcript variant X5
enhancer of zeste 1 polycomb repressive complex 2 subunit, transcript variant X2
enhancer of zeste 1 polycomb repressive complex 2 subunit, transcript variant X1
enhancer of zeste 1 polycomb repressive complex 2 subunit, transcript variant X3
histone-lysine N-methyltransferase EZH1 isoform X2
histone-lysine N-methyltransferase EZH1 isoform X1
histone-lysine N-methyltransferase EZH1 isoform X3
histone-lysine N-methyltransferase EZH1 isoform X5
enhancer of zeste 1 polycomb repressive complex 2 subunit, transcript variant X4
histone-lysine N-methyltransferase EZH1 isoform X4
receptor activity-modifying protein 1-like
receptor activity modifying protein 2, transcript variant X2
receptor activity modifying protein 2, transcript variant X3
receptor activity-modifying protein 2 isoform X2
receptor activity-modifying protein 2 isoform X3
receptor activity modifying protein 2, transcript variant X1
receptor activity-modifying protein 2 isoform X1
vacuolar protein sorting 25 homolog, transcript variant X1
vacuolar protein-sorting-associated protein 25 isoform X1
vacuolar protein sorting 25 homolog, transcript variant X2
vacuolar protein-sorting-associated protein 25 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine/threonine-protein kinase WNK4
cytochrome c oxidase assembly factor 3 homolog, mitochondrial
cyclin N-terminal domain containing 1, transcript variant X1
cyclin N-terminal domain containing 1, transcript variant X2
cyclin N-terminal domain-containing protein 1 isoform X1
cyclin N-terminal domain-containing protein 1 isoform X2
membrane primary amine oxidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
membrane primary amine oxidase-like isoform X1
membrane primary amine oxidase-like, transcript variant X2
membrane primary amine oxidase-like, transcript variant X3
membrane primary amine oxidase-like isoform X2
amine oxidase copper containing 3, transcript variant X2
amine oxidase copper containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
membrane primary amine oxidase isoform X2
membrane primary amine oxidase isoform X1
amine oxidase copper containing 3, transcript variant X3
membrane primary amine oxidase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glucose-6-phosphatase-like, transcript variant X5
glucose-6-phosphatase-like, transcript variant X1
glucose-6-phosphatase-like, transcript variant X2
glucose-6-phosphatase-like, transcript variant X4
glucose-6-phosphatase-like, transcript variant X3
glucose-6-phosphatase-like, transcript variant X6
uncharacterized protein LOC120392055 isoform X3
prostaglandin E synthase 3 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
prostaglandin E synthase 3 like, transcript variant X1
prostaglandin E synthase 3 like, transcript variant X2
RUN domain containing 1, transcript variant X3
RUN domain containing 1, transcript variant X1
RUN domain-containing protein 1 isoform X1
RUN domain-containing protein 1 isoform X3
RUN domain containing 1, transcript variant X2
RUN domain-containing protein 1 isoform X2
interferon induced protein 35, transcript variant X3
interferon induced protein 35, transcript variant X6
interferon induced protein 35, transcript variant X1
interferon induced protein 35, transcript variant X7
interferon induced protein 35, transcript variant X4
interferon induced protein 35, transcript variant X8
interferon induced protein 35, transcript variant X5
interferon induced protein 35, transcript variant X2
interferon-induced 35 kDa protein isoform X1
interferon-induced 35 kDa protein isoform X3
interferon-induced 35 kDa protein isoform X2
interferon-induced 35 kDa protein isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
synaptic vesicle membrane protein VAT-1 homolog
BRCA1 DNA repair associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BRCA1 DNA repair associated, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BRCA1 DNA repair associated, transcript variant X3
breast cancer type 1 susceptibility protein
NBR1 autophagy cargo receptor, transcript variant X2
NBR1 autophagy cargo receptor, transcript variant X6
NBR1 autophagy cargo receptor, transcript variant X1
NBR1 autophagy cargo receptor, transcript variant X9
NBR1 autophagy cargo receptor, transcript variant X5
NBR1 autophagy cargo receptor, transcript variant X8
NBR1 autophagy cargo receptor, transcript variant X3
NBR1 autophagy cargo receptor, transcript variant X10
NBR1 autophagy cargo receptor, transcript variant X4
NBR1 autophagy cargo receptor, transcript variant X7
transmembrane protein 106A, transcript variant X2
transmembrane protein 106A, transcript variant X3
transmembrane protein 106A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DEAH-box helicase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DEAH-box helicase 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATP-dependent RNA helicase DHX8 isoform X1
ATP-dependent RNA helicase DHX8 isoform X2
DEAH-box helicase 8, transcript variant X3
ATP-dependent RNA helicase DHX8 isoform X3
ETS variant transcription factor 4, transcript variant X4
ETS variant transcription factor 4, transcript variant X3
ETS variant transcription factor 4, transcript variant X5
ETS variant transcription factor 4, transcript variant X2
ETS variant transcription factor 4, transcript variant X1
ETS variant transcription factor 4, transcript variant X7
ETS variant transcription factor 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual specificity phosphatase 3, transcript variant X4
dual specificity phosphatase 3, transcript variant X3
dual specificity phosphatase 3, transcript variant X2
dual specificity phosphatase 3, transcript variant X1
dual specificity phosphatase 3, transcript variant X6
dual specificity phosphatase 3, transcript variant X7
dual specificity phosphatase 3, transcript variant X8
dual specificity phosphatase 3, transcript variant X9
dual specificity protein phosphatase 3 isoform X4
dual specificity protein phosphatase 3 isoform X3
dual specificity protein phosphatase 3 isoform X2
dual specificity protein phosphatase 3 isoform X1
dual specificity protein phosphatase 3 isoform X6
dual specificity phosphatase 3, transcript variant X5
dual specificity protein phosphatase 3 isoform X5
CFAP97 domain containing 1, transcript variant X2
sperm axonemal maintenance protein CFAP97D1 isoform X2
CFAP97 domain containing 1, transcript variant X3
CFAP97 domain containing 1, transcript variant X1
sperm axonemal maintenance protein CFAP97D1 isoform X3
sperm axonemal maintenance protein CFAP97D1 isoform X1
membrane palmitoylated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
membrane palmitoylated protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G protein-activated inward rectifier potassium channel 1-like, transcript variant X3
G protein-activated inward rectifier potassium channel 1-like, transcript variant X2
G protein-activated inward rectifier potassium channel 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G protein-activated inward rectifier potassium channel 1-like isoform X1
G protein-activated inward rectifier potassium channel 1-like isoform X3
G protein-activated inward rectifier potassium channel 1-like isoform X2
uncharacterized LOC120392074, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC120392074, transcript variant X7
uncharacterized LOC120392074, transcript variant X1
uncharacterized LOC120392074, transcript variant X4
uncharacterized LOC120392074, transcript variant X2
uncharacterized LOC120392074, transcript variant X5
uncharacterized LOC120392074, transcript variant X6
uncharacterized LOC120392074, transcript variant X8
uncharacterized LOC120392075, transcript variant X5
uncharacterized LOC120392075, transcript variant X3
uncharacterized LOC120392075, transcript variant X2
uncharacterized LOC120392075, transcript variant X1
uncharacterized LOC120392075, transcript variant X4